RKH Specialty has placed a new healthcare and life science facility on behalf of Ryan Specialty’s Healthcare underwriting businesses. Support for the facility comes from the leading healthcare markets including Amlin, Chaucer, Catlin, Hiscox, Atrium, Renaissance Re and Dale. The facility creates the largest, single healthcare coverholder arrangement in Lloyd’s.
The facility can encompass a very broad array of healthcare and life science businesses including long-term care, allied healthcare, specialty and rehabilitation hospitals, as well as generic pharmaceuticals, branded pharmaceuticals, medical products, nutritional supplements and clinical trials. The facility offers limits for both healthcare and life science up to $25m.
Commenting on the deal Al Carter, RKH Specialty’s head of Healthcare said:
“This facility is the result of a detailed and pragmatic process. It provides Ryan Specialty’s Healthcare underwriting division with a platform to further grow its successful Sapphire Blue and Life Science Risk (LSR) programmes via the US broker community. In addition, it provides the Lloyd’s market with a stream of healthcare business underwritten by the recognised leading underwriters in their respective fields that otherwise would not naturally flow into Lloyd’s.
“The commitment from Ryan Specialty Group and the Lloyd’s underwriters broke new ground in terms of the integrated programme’s scope, breadth and ability to bring together leading underwriters under a single programme with two distinct classes of business.”
In addition to Healthcare, RKH Specialty’s expertise in every aspect of the design, placement and servicing of successful programmes has led to work across many specialist industry areas, including:
- Financial Institutions
- Public entity
- Real Estate
For more information about RKH Specialty Healthcare, contact Al Carter.
For information about Facilities, contact Nigel Bridgwater.